Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RET c.1901G>A and Novel SLC12A3 Mutations in Familial Pheochromocytomas | Genes (Basel) | 2022 | 35627249 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge? | Cells | 2022 | 35626699 | PubTator, text mining | PubMed |
| Stressing the Regulatory Role of Long Non-Coding RNA in the Cellular Stress Response during Cancer Progression and Therapy. | Biomedicines | 2022 | 35625948 | PubTator, text mining | PubMed |
| Robustness of the Krebs Cycle under Physiological Conditions and in Cancer: New Clues for Evaluating Metabolism-Modifying Drug Therapies. | Biomedicines | 2022 | 35625935 | PubTator, text mining | PubMed |
| Genetic Alterations in Benign Adrenal Tumors. | Biomedicines | 2022 | 35625779 | PubTator, text mining | PubMed |
| The aerobic electron flux is deficient in fumarate respiration of a strict anaerobe Bacteroides thetaiotaomicron. | Biochem Biophys Res Commun | 2022 | 35623108 | PubTator, text mining | PubMed |
| Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities. | Front Oncol | 2022 | 35619925 | PubTator, text mining | PubMed |
| Metabolomic Profiling of Peripheral Plasma by GC-MS and Correlation With Size of Uterine Leiomyomas. | J Endocr Soc | 2022 | 35611322 | PubTator, text mining | PubMed |
| Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine. | EPMA J | 2022 | 35578648 | PubTator, text mining | PubMed |
| Epigenetic editing and tumor-dependent immunosuppressive signaling in head and neck malignancies. | Oncol Lett | 2022 | 35572491 | PubTator, text mining | PubMed |
| Proteomics in Multiple Sclerosis: The Perspective of the Clinician. | Int J Mol Sci | 2022 | 35563559 | PubTator, text mining | PubMed |
| Cytopathological Outcomes of Knocking down Expression of Mitochondrial Complex II Subunits in Dictyostelium discoideum. | Int J Mol Sci | 2022 | 35563430 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors. | Sci Adv | 2022 | 35559673 | PubTator, text mining | PubMed |
| Henri-Michaelis-Menten kinetics of reversible enzymic reactions, and the determination of rate constants from kinetic constants. | Sci Prog | 2022 | 35549765 | PubTator, text mining | PubMed |
| Pancreatic INS-1 β-Cell Response to Thapsigargin and Rotenone: A Comparative Proteomics Analysis Uncovers Key Pathways of β-Cell Dysfunction. | Chem Res Toxicol | 2022 | 35544339 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission. | Front Genet | 2022 | 35495123 | PubTator, text mining | PubMed |
| Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry. | iScience | 2022 | 35494234 | PubTator, text mining | PubMed |
| Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer. | Cold Spring Harb Mol Case Stud | 2022 | 35483881 | PubTator, text mining | PubMed |
| Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics. | Front Oncol | 2022 | 35463327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=38